Shortwave Life Sciences Reports “Positive” Drug Safety Results | Psychedelic Invest

Toronto, Ontario–(Newsfile Corp. – September 19, 2024) – PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and previously approved drugs, is announcing it has initiated start-up activities for its first clinical study of…

Physician Burnout Rate Drops; Tattoo Ink Contamination; Dengue Fever in Florida

Note that some links may require registration or subscription. Note that Morning Break will not be published on Thursday, July 4; we will be back

July 4, 2024

Beyond BMI: New framework for obesity diagnosis prioritizes overall health

The system for diagnosing and managing obesity can no longer be about just body mass index (BMI), which is excluding many people who would benefit

July 8, 2024

Alnylam reports growth in sales of rare disease treatments

Alnylam Pharmaceuticals said Thursday that sales of its treatments for rare diseases grew 43% in the second quarter compared to the year-ago period, as the

August 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.